Monte Carlo simulation engines for benefit cost forecasting, stop-loss optimization, and multi-year trend projection with confidence intervals and scenario planning.
10,000-run simulations model future benefit costs under varying claim frequency, severity, and trend scenarios. Produces confidence intervals, percentile ranges, and tail risk quantification.
Calculate optimal specific and aggregate attachment points that balance premium costs against expected reimbursements. Models laser placements for known high-cost claimants.
Apply actuarial credibility theory to blend plan-specific experience with industry benchmarks. Small populations get more industry weighting, large populations trust their own data.
Project costs 3-5 years forward incorporating demographic shifts, utilization trends, drug pipeline launches, and contract renewal scenarios. Supports long-term budgeting and M&A modeling.
Model cost impact of adding/removing specialty medications from formulary. Simulate shift from brand to biosimilar, or adoption of new GLP-1 therapies across eligible population.
Test deductible increases, copay tier shifts, or coinsurance adjustments. Predict member out-of-pocket costs, plan savings, and utilization changes before renewal implementation.
Validate carrier renewal quotes against your own actuarial projections. Identify inflated trend assumptions, excessive margin loads, or understated rebate pass-through.
Comprehensive governance framework for board members and plan fiduciaries — defense-ready documentation and continuous oversight infrastructure.
Timestamped audit trail with complete chain of custody
EBITDA quantification and board-ready financial models
Cross-system verification and data integrity validation
Automated clause extraction and guarantee enforcement
Monte Carlo simulations and credibility-weighted forecasts
Transaction-level anomaly detection and forensic alerts
ERISA compliance monitoring and DOL audit readiness
AI-powered trend forecasting and intervention modeling